Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02578862 · ClinicalTrials.gov registry record · Phase 4
Total Intravenous Anesthesia in Sinus Surgery
A Phase 4 study, sponsored by Ochsner Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 72
- Enrollment target
NCT02578862 is a Phase 4 study that has completed, run by Ochsner Health System. The registered enrollment target is 72 participants.
The verdict
NCT02578862, a Phase 4 study, has completed, sponsored by Ochsner Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 72 participants
- Enrollment target
Study Summary
Utilization of total intravenous anesthesia (TIVA) has been proposed as a method to improve visualization during endoscopic sinus surgery (ESS), largely due to its physiologic decrease in cardiac output without the peripheral smooth muscle relaxation and resultant vasodilation associated with inhaled anesthetics. This may be especially important in cases of advanced inflammatory sinus disease, when visualization may be most compromised. The goal of this study is to improve clinical practice paradigms by evaluating the use of TIVA versus inhaled anesthetic for maintenance of anesthesia in ESS for advanced paranasal sinus disease.
Interventions
- DRUG Sevoflurane
- DRUG Propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2015-07 |
| Est. Completion | 2018-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02578862
The ClinicalTrials.gov registry entry for NCT02578862 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ochsner Health System, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sevoflurane is the first listed.
NCT02578862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02578862 about?
NCT02578862 is a clinical study titled "Total Intravenous Anesthesia in Sinus Surgery". Utilization of total intravenous anesthesia (TIVA) has been proposed as a method to improve visualization during endoscopic sinus surgery (ESS), largely due to its physiologic decrease in cardiac output without the peripheral smooth muscle relaxation and resultant vasodilation associated with inhale...
What is the current status of trial NCT02578862?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 72 participants. The study started on 2015-07. Estimated completion is 2018-06.
What interventions are being tested in trial NCT02578862?
The interventions under investigation include: Sevoflurane (DRUG), Propofol (DRUG).
Who is sponsoring clinical trial NCT02578862?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.